Overview
Ipamorelin is a peptide that acts as a ghrelin/growth-hormone secretagogue receptor agonist, studied for its ability to stimulate the body's own growth-hormone release with relative selectivity.
How It's Thought to Work
It mimics ghrelin at the GHS-R receptor, prompting the pituitary to release growth hormone, reportedly with less effect on cortisol and prolactin than some older secretagogues.
What the Research Says
Early-stage and preclinical research exists; robust human clinical outcome data is limited. Often discussed alongside CJC-1295.
Regulatory & Legal Status
Not approved by the FDA for human use. Sold as a research chemical. Prohibited in sport by WADA.
Safety Considerations
Limited human safety data; unregulated product quality. Consult a qualified clinician.